New to Podcasts?
Selumetinib for lung cancer, postmarket drug safety, screening for thyroid cancer, and more

JAMA Editor’s Summary

Selumetinib for lung cancer, postmarket drug safety, screening for thyroid cancer, and more

Selumetinib for lung cancer, postmarket drug safety, screening for thyroid cancer, and more

May 09, 2017 edition of the weekly JAMA Editors’ Summary

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover Welcome to the Health Podcast Network!
00:00
00:00
volume-low